This week, a self-delivering drug for retinal scarring seems safe, the world’s tallest teen undergoes keratoconus treatment and researchers reveal how blue light from smartphones speeds visual decline. Source: AAO
Researchers assessed the efficacy of internal limiting membrane (ILM) peeling for retinal detachments complicated by grade B proliferative vitreoretinopathy (PVR). Source: AAO
This case study reviews the natural history and clinical and radiological characteristics of primary pediatric optic nerve sheath meningioma. Source: AAO
This paper presents the visual outcomes of children with orbital cellulitis and globe tenting. Source: AAO
This is the largest study to characterize the clinical features and course of blue nevus on the ocular surface. Source: AAO
This single-center prospective analysis assessed the effects of repeated intravitreal dexamethasone inserts in patients with noninfectious uveitis and cystoid macular edema or vitritis. Source: AAO
This week, Alcon unveils forceps with a shark-like grip, rogue immune cells provoke dry eye disease and artificial intelligence uses eye movements to discern personality traits. Source: AAO
A mid-stage study of a miotic topical solution shows that it safely improves near vision in people with presbyopia, according to a press release by Presbyopia Therapies, LLC. Source: AAO
This is the first study to examine the association between systemic medication and primary open-angle glaucoma (POAG) across all known drugs and drug classes. Source: AAO
Investigators retrospectively assessed the effect of a rapid tissue warming protocol on tissue evaluation times and specular image quality. Source: AAO